Demirağ, A. D. Et Al. 2023. The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study. Open Journal of Nano , vol.8, no.2 , 1-9.

Demirağ, A. D., Çelik, S., Aslan, S., Özel, A., & Akyüz, S., (2023). The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study. Open Journal of Nano , vol.8, no.2, 1-9.

Demirağ, Aliye Et Al. "The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study," Open Journal of Nano , vol.8, no.2, 1-9, 2023

Demirağ, Aliye D. Et Al. "The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study." Open Journal of Nano , vol.8, no.2, pp.1-9, 2023

Demirağ, A. D. Et Al. (2023) . "The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study." Open Journal of Nano , vol.8, no.2, pp.1-9.

@article{article, author={Aliye Demet Demirağ Et Al. }, title={The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study}, journal={Open Journal of Nano}, year=2023, pages={1-9} }